• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health.

作者信息

Eslam Mohammed, Fan Jian-Gao, Mendez-Sanchez Nahum

机构信息

Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney 2145, NSW, Australia.

Center for Fatty Liver, Department of Gastroenterology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China.

出版信息

Lancet Gastroenterol Hepatol. 2020 Aug;5(8):713-715. doi: 10.1016/S2468-1253(20)30090-X. Epub 2020 May 12.

DOI:10.1016/S2468-1253(20)30090-X
PMID:32413341
Abstract
摘要

相似文献

1
Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health.非肥胖个体中的非酒精性脂肪性肝病：代谢健康的影响
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):713-715. doi: 10.1016/S2468-1253(20)30090-X. Epub 2020 May 12.
2
[Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases].非肥胖型非酒精性脂肪性肝病的诊断与治疗策略
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):203-207. doi: 10.3760/cma.j.cn501113-20191226-00480.
3
Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.中国南方超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率及风险增加。
Diabet Med. 2017 Apr;34(4):505-513. doi: 10.1111/dme.13174. Epub 2016 Sep 15.
4
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.《生命线研究中非酒精性脂肪性肝病的患病率及影响因素：一项大型荷兰人群队列研究》
PLoS One. 2017 Feb 2;12(2):e0171502. doi: 10.1371/journal.pone.0171502. eCollection 2017.
5
Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.非酒精性脂肪性肝病患者的风险因素和代谢异常：非肥胖或肥胖的中国人群。
Hepatobiliary Pancreat Dis Int. 2018 Feb;17(1):45-48. doi: 10.1016/j.hbpd.2018.01.007. Epub 2018 Jan 31.
6
Comparison between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children.儿科健康促进中心与儿科肥胖诊所对儿童代谢综合征和非酒精性脂肪性肝病检测能力的比较。
J Korean Med Sci. 2014 Dec;29(12):1672-7. doi: 10.3346/jkms.2014.29.12.1672. Epub 2014 Nov 21.
7
Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.无代谢综合征的严重肥胖受试者中经活检证实的非酒精性脂肪性肝病患病率
Clin Obes. 2016 Apr;6(2):117-23. doi: 10.1111/cob.12132. Epub 2016 Feb 8.
8
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.系统评价：多囊卵巢综合征与代谢综合征和非酒精性脂肪性肝病的关系。
Aliment Pharmacol Ther. 2011 Apr;33(7):801-14. doi: 10.1111/j.1365-2036.2011.04579.x. Epub 2011 Jan 20.
9
Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.接受减肥手术的重度肥胖南印度患者中非酒精性脂肪性肝病的患病率及预测因素
Obes Surg. 2015 Nov;25(11):2078-87. doi: 10.1007/s11695-015-1655-1.
10
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价：成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.

引用本文的文献

1
HOMA-IR, an independent predictor of advanced liver fibrosis in metabolic-dysfunction associated fatty liver disease: a cross-sectional study in Egyptian patients.HOMA-IR是代谢功能障碍相关脂肪性肝病中晚期肝纤维化的独立预测指标：一项针对埃及患者的横断面研究。
Sci Rep. 2025 Aug 24;15(1):31098. doi: 10.1038/s41598-025-15425-7.
2
Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease.多组学分析揭示代谢功能障碍相关脂肪性肝病中的跨界肠道生态失调。
Nat Metab. 2025 Jul 2. doi: 10.1038/s42255-025-01318-6.
3
Alternative splicing: hallmark and therapeutic opportunity in metabolic liver disease.
可变剪接：代谢性肝病的标志与治疗契机
Gastroenterol Rep (Oxf). 2025 May 26;13:goaf044. doi: 10.1093/gastro/goaf044. eCollection 2025.
4
Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort study.非肝硬化性MAFLD相关肝细胞癌的特征：一项回顾性队列研究。
Ther Adv Chronic Dis. 2025 May 16;16:20406223251339402. doi: 10.1177/20406223251339402. eCollection 2025.
5
The causal impact of body mass index on metabolic biomarkers and nonalcoholic fatty liver disease risk.体重指数对代谢生物标志物及非酒精性脂肪性肝病风险的因果影响。
Sci Rep. 2025 Mar 25;15(1):10314. doi: 10.1038/s41598-024-84165-x.
6
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.亚太肝脏研究协会代谢功能障碍相关脂肪性肝病诊断和管理临床实践指南
Hepatol Int. 2025 Apr;19(2):261-301. doi: 10.1007/s12072-024-10774-3. Epub 2025 Feb 27.
7
Dietary and lifestyle indices for hyperinsulinemia and odds of MAFLD in overweight and obese children and adolescents.超重和肥胖儿童及青少年中高胰岛素血症的饮食和生活方式指数与MAFLD的发生几率
Sci Rep. 2025 Feb 6;15(1):4465. doi: 10.1038/s41598-025-88969-3.
8
Impact of bariatric surgery on liver fibrosis indices among type 2 diabetes patients in a national cohort.减肥手术对全国队列中2型糖尿病患者肝脏纤维化指标的影响。
Sci Rep. 2025 Jan 7;15(1):1235. doi: 10.1038/s41598-025-85427-y.
9
Maternal Abnormal Liver Function in Early Pregnancy and Spontaneous Pregnancy Loss: A Retrospective Cohort Study.孕早期母体肝功能异常与自然流产：一项回顾性队列研究。
J Epidemiol. 2025 May 5;35(5):230-236. doi: 10.2188/jea.JE20240233. Epub 2025 Mar 31.
10
The Different Predictive Effects of Multiple Body Fat Indexes on Metabolic Dysfunction-Associated Fatty Liver Disease.多种体脂指数对代谢功能障碍相关脂肪性肝病的不同预测作用。
Diabetes Metab Syndr Obes. 2024 Oct 19;17:3875-3890. doi: 10.2147/DMSO.S469859. eCollection 2024.